The biological paths of IL-1 family members IL-18 and IL-33

被引:104
作者
Smith, Dirk E. [1 ]
机构
[1] Amgen Inc, Dept Inflammat Res, Seattle, WA 98119 USA
关键词
cytokine; inflammation; disease; RECEPTOR ACCESSORY PROTEIN; NECROSIS-FACTOR-ALPHA; SOLUBLE ST2 PROTEIN; CD4(+) T-CELLS; CYTOKINE PRODUCTION; CUTTING EDGE; IMMUNE-RESPONSE; INTERLEUKIN-1; RECEPTOR; AIRWAY INFLAMMATION; INVARIANT NKT;
D O I
10.1189/jlb.0810470
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Cytokines are key mediators of the immune system, and few have been more thoroughly studied than those of the IL-1 family. IL-1 alpha and IL-1 beta are the founding members and now celebrate 25 years since their cloning. In that time, IL-1-directed research has illuminated many aspects of cytokine biology and innate immunity. The family is now recognized to include 11 total members, including IL-18 and IL-33, which are the topic of this review. These two inflammatory cytokines are expressed broadly, and their actions influence a variety of physiologic responses involved in inflammation and immunity. The purpose of this article is not to provide an exhaustive review of IL-18 and IL-33 but rather, to summarize what is known about their key functions and to provide perspective on their similarities and differences. J. Leukoc. Biol. 89: 383-392; 2011.
引用
收藏
页码:383 / 392
页数:10
相关论文
共 171 条
[1]   Involvement of caspase-1 and caspase-3 in the production and processing of mature human interleukin 18 in monocytic THP.1 cells [J].
Akita, K ;
Ohtsuki, T ;
Nukada, Y ;
Tanimoto, T ;
Namba, M ;
Okura, T ;
TakakuraYamamoto, R ;
Torigoe, K ;
Gu, Y ;
Su, MSS ;
Fujii, M ;
SatohItoh, M ;
Yamamoto, K ;
Kohno, K ;
Ikeda, M ;
Kurimoto, M .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (42) :26595-26603
[2]   IL-1 receptor accessory protein is essential for IL-33-induced activation of T lymphocytes and mast cells [J].
Ali, Shafaqat ;
Hubert, Michael ;
Kollewe, Christian ;
Bischoff, Stephan C. ;
Falk, Werner ;
Martin, Michael U. .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2007, 104 (47) :18660-18665
[3]   CD34+ hemopoietic progenitor cells are potent effectors of allergic inflammation [J].
Allakhverdi, Zoulfia ;
Comeau, Michael R. ;
Smith, Dirk E. ;
Toy, Dean ;
Endam, Leandra Mfuna ;
Desrosiers, Martin ;
Liu, Yong-Jun ;
Howie, Karen J. ;
Denburg, Judah A. ;
Gauvreau, Gail M. ;
Delespesse, Guy .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2009, 123 (02) :472-478
[4]   Cutting edge: The ST2 ligand IL-33 potently activates and drives maturation of human mast cells [J].
Allakhverdi, Zouna ;
Smith, Dirk E. ;
Comeau, Michael R. ;
Delespesse, Guy .
JOURNAL OF IMMUNOLOGY, 2007, 179 (04) :2051-2054
[5]   Interleukin-33 attenuates sepsis by enhancing neutrophil influx to the site of infection [J].
Alves-Filho, Jose C. ;
Sonego, Fabiane ;
Souto, Fabricio O. ;
Freitas, Andressa ;
Verri, Waldiceu A., Jr. ;
Auxiliadora-Martins, Maria ;
Basile-Filho, Anibal ;
McKenzie, Andrew N. ;
Xu, Damo ;
Cunha, Fernando Q. ;
Liew, Foo Y. .
NATURE MEDICINE, 2010, 16 (06) :708-U113
[6]   IL-1, IL-18, and IL-33 families of cytokines [J].
Arend, William P. ;
Palmer, Gaby ;
Gabay, Cem .
IMMUNOLOGICAL REVIEWS, 2008, 223 :20-38
[7]   Molecular characterization of NF-HEV, a nuclear factor preferentially expressed in human high endothelial venules [J].
Baekkevold, ES ;
Roussigné, M ;
Yamanaka, T ;
Johansen, FE ;
Jahnsen, FL ;
Amalric, F ;
Brandtzaeg, P ;
Erard, M ;
Haraldsen, G ;
Girard, JP .
AMERICAN JOURNAL OF PATHOLOGY, 2003, 163 (01) :69-79
[8]   Prointerleukin-18 Is Activated by Meprin β in Vitro and in Vivo in Intestinal Inflammation [J].
Banerjee, Sanjita ;
Bond, Judith S. .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2008, 283 (46) :31371-31377
[9]   Characterization of the Novel ST2/IL-33 System in Patients with Inflammatory Bowel Disease [J].
Beltran, Carol J. ;
Nunez, Lucia E. ;
Diaz-Jimenez, David ;
Farfan, Nancy ;
Candia, Enzo ;
Heine, Claudio ;
Lopez, Francisco ;
Julieta Gonzalez, Maria ;
Quera, Rodrigo ;
Hermoso, Marcelo A. .
INFLAMMATORY BOWEL DISEASES, 2010, 16 (07) :1097-1107
[10]  
Bohn E, 1998, J IMMUNOL, V160, P299